ArdorComm Media Group

Wednesday, October 22, 2025 6:22 AM

Health & Wellness Community

Scientists Explore How Music Can Help Relieve Pain from Surgery and Illness

In the recovery ward at UC San Diego Health, nurse Rod Salaysay relies on more than just medical tools like a stethoscope or thermometer — he also uses his guitar and ukulele. Between post-surgery medications, Salaysay plays tunes at patients’ request, ranging from folk songs and classical pieces like Minuet in G Major to movie classics such as Somewhere Over the Rainbow. The results are often visible: patients smile, relax, and sometimes even require fewer painkillers. “In hospitals, pain, anxiety, and worry often feed into each other,” Salaysay explained. “Music can help break that cycle.” Over the last twenty years, hospitals and clinics worldwide have increasingly turned to music therapy — both live and recorded — as studies continue to reveal its power to ease physical and emotional pain. While music’s emotional influence has long been understood, scientists are only now uncovering how music-induced analgesia — the process by which music reduces pain perception — actually works. Although a melody can’t replace strong pain medication, research published in Pain and Scientific Reports shows that listening to music can lessen pain intensity and increase a person’s tolerance to discomfort. What seems crucial, researchers say, is that patients choose the music themselves and listen attentively, rather than passively. “Pain is incredibly complex,” said Adam Hanley, a psychologist at Florida State University. “It’s shaped by both the body’s sensations and our emotional and mental responses to those sensations.” Even with the same condition, two people might experience pain differently. Acute pain comes from immediate physical triggers, while chronic pain involves long-term changes in the brain that heighten sensitivity. “Pain is processed and interpreted by the brain,” said Dr. Gilbert Chandler, a chronic spinal pain expert from Tallahassee Orthopedic Clinic, “and the brain can amplify or reduce those signals.” Music, experts note, helps redirect attention away from pain. Studies suggest that preferred music is especially effective, even more than podcasts or generic playlists. “Music doesn’t just distract — it engages the whole brain,” said Caroline Palmer, a psychologist at McGill University. “That’s why it changes how people experience pain.” Indeed, Kate Richards Geller, a Los Angeles-based music therapist, explains that engaging with music activates nearly every brain region, easing not just pain but also isolation and anxiety. The use of music for pain relief dates back to the 19th century, when patients listened to melodies during dental procedures before anesthetics were common. Modern researchers continue to explore what makes it most effective. In one experiment at Erasmus University Rotterdam, scientists tested 548 participants across five music genres — classical, rock, pop, urban, and electronic — to measure how long they could withstand cold-induced pain. All genres helped, but none outperformed the others. “The best music is simply what you like,” said study co-author Dr. Emy van der Valk Bouman, noting that familiar songs may trigger memories and emotions that enhance resilience. Allowing patients to choose their music can also restore a sense of control and agency, said Claire Howlin of Trinity College Dublin, whose research shows that self-selected songs can boost pain tolerance. Hanley’s studies further indicate that focused, daily listening may gradually reduce chronic pain, offering an uplifting “emotional bump” without side effects. For many, it’s a powerful, drug-free remedy. Cecily Gardner, a jazz vocalist from California, said music helped her cope with illness and brought comfort to others in pain. “Music reduces stress, connects people,” she said, “and transports you somewhere better.” Source: AP

Scientists Explore How Music Can Help Relieve Pain from Surgery and Illness Read More »

Bengaluru’s Airbound Partners with Narayana Health to Launch Drone-Based Medical Deliveries

ardorcomm news

Bengaluru-based autonomous logistics startup Airbound has joined hands with Narayana Health to pilot medical deliveries using drones, marking a major step toward integrating advanced drone technology into India’s healthcare logistics system. As part of the three-month pilot programme, Airbound will carry out around 10 drone-based deliveries per day, transporting critical medical items such as blood samples, diagnostic test kits, and essential supplies between healthcare facilities. “This collaboration with Narayana Health demonstrates our ability to handle the most demanding delivery needs while showcasing the cost benefits that make our model globally scalable,” said Naman Pushp, Founder and CEO of Airbound. Airbound described the initiative as a “high-stakes proof of concept” designed to validate drone technology’s reliability, efficiency, and cost-effectiveness for critical healthcare applications. Dr. Devi Shetty, Founder and Chairman of Narayana Health, noted, “Our partnership with Airbound enables us to explore a promising technology that can greatly enhance the speed and dependability of medical logistics. This aligns with our mission to harness innovation for improving patient outcomes, especially in situations where rapid access to diagnostics and supplies can be life-saving.” Airbound’s drones are capable of carrying a payload-to-aircraft mass ratio of 1 kg to 1.5 kg. The company highlighted that its blended-wing-body tailsitter design allows vertical takeoff and landing while maintaining the aerodynamic efficiency of fixed-wing flight—addressing the limitations found in traditional tilt-rotor and quadplane configurations. In addition to the partnership, Airbound announced securing $8.65 million in seed funding, led by Lachy Groom (Co-founder, Physical Intelligence), with participation from Humba Ventures, Lightspeed Venture Partners, and senior executives from Tesla, Anduril, and Ather Energy. With this round, Airbound’s total funding has surpassed $10 million. The company plans to use the funds to scale up manufacturing, expand beyond healthcare logistics, refine its drone technology, and prepare for large-scale market deployment by 2026. Insights gained from the Narayana Health pilot will help Airbound enhance its future logistics solutions, cut delivery costs, and accelerate adoption across multiple sectors. Source: The Hindu

Bengaluru’s Airbound Partners with Narayana Health to Launch Drone-Based Medical Deliveries Read More »

Study Identifies 750 Genes Influencing Human Metabolism Through Blood Molecules

ardorcomm news

A large-scale genetic study has identified around 750 genes that may play a key role in human metabolism by regulating levels of approximately 250 different blood molecules, including lipids and amino acids. The research suggests these genetic influences are consistent across ancestries and genders, offering broad implications for understanding metabolic health. The study, led by scientists from the Berlin Institute of Health at Charité–Universitätsmedizin Berlin and Queen Mary University of London, analysed genetic data from nearly 4.5 lakh individuals of European, African, and Asian ancestry in the UK Biobank. Published in Nature Genetics, the findings revealed 29,824 genetic locus–metabolite associations mapped to 753 genomic regions, many of which had not previously been linked to metabolic processes. This discovery expands current knowledge of metabolic pathways and their connection to disease risks. The researchers found that the genetic regulation of blood metabolites showed strong consistency across populations, suggesting the potential for universal metabolic insights. Some of the identified genes, such as VEGFA, were newly linked to cholesterol regulation and may open pathways for novel drug development aimed at preventing heart disease. Lead author Martijn Zoodsma, a postdoctoral researcher at BIH, said the study offers a “systematic map of the genetic control of hundreds of blood molecules,” providing a valuable foundation for understanding disease susceptibility and metabolic diversity. Senior author Prof. Maik Pietzner added that despite advances like statins, heart disease remains a leading cause of death, and these findings could guide the creation of next-generation therapies targeting lipid build-up in arteries. Source: PTI  

Study Identifies 750 Genes Influencing Human Metabolism Through Blood Molecules Read More »

IAP Kerala Urges Caution: Avoid Self-Medication and Follow Rational Prescription for Children’s Illnesses

ardorcomm news

The Indian Academy of Paediatrics (IAP), Kerala chapter, has issued a strong advisory urging parents to avoid self-medicating children and instead seek professional paediatric consultation for managing common illnesses like cough and cold. The academy has also called on healthcare providers to follow rational prescription practices to ensure safe and effective treatment for young patients. The guidance follows a recent directive from the Drugs Controller General of India (DCGI), which prohibits the prescription of cough syrups for children under two years of age. “The DCGI’s directive is a reminder to ensure rational use of medicines, especially in infants and young children,” said Dr. I. Riaz, President of IAP Kerala. “Parents should resist the urge to purchase over-the-counter cough syrups or reuse old prescriptions. For persistent cough, consulting a paediatrician for proper diagnosis and dosage is essential.” The IAP Kerala further advised that combination cough and cold medications should not be prescribed for children below two years, and their use in older children should only follow thorough medical evaluation and careful supervision. Dr. Riaz explained that cough is often a symptom of underlying issues such as asthma, allergies, dehydration, or post-nasal drip. Most cases of acute cough in children are self-limiting and resolve without medication. For children above six months, paediatricians may prescribe antihistamines or bronchodilators when clinically necessary, using correct doses and minimal duration. When treating asthma or wheezing-related cough, bronchodilators are best administered through a Metered Dose Inhaler (MDI) with spacer, a method both safe and effective for children. The academy emphasized non-drug measures—like adequate hydration, rest, saline nasal drops, and supportive care—as the first line of treatment for most childhood coughs. “All coughs are not the same, and parents must avoid repeating old prescriptions,” Dr. Riaz cautioned. “Medication type, dosage, and duration should always be adjusted as a child grows.” Source: The Hindu

IAP Kerala Urges Caution: Avoid Self-Medication and Follow Rational Prescription for Children’s Illnesses Read More »

Kidney Cancer Cases Could Nearly Double Worldwide by 2050: Study

ardorcomm news

A new global study warns that kidney cancer cases may almost double over the next quarter century if current health trends continue. Researchers from Europe, the US, and the UK examined data from the Global Cancer Observatory of the International Agency for Research on Cancer, projecting a dramatic surge in both incidence and mortality. In 2022, around 435,000 new cases and 156,000 deaths from kidney cancer were recorded worldwide. By 2050, the figures could rise to nearly 746,000 cases (a 72% increase) and over 304,000 deaths (a 96% rise), according to findings published in European Urology. The rise is linked largely to modifiable risk factors such as obesity, hypertension, diabetes, smoking, and physical inactivity, alongside environmental exposures. While 5–8% of cases are estimated to have a genetic basis, researchers emphasized that more than half of all kidney cancer cases are preventable. “Kidney cancer is becoming a global health challenge. Clinicians and policymakers must brace for this sharp increase,” said senior author Alexander Kutikov, Chair of the Department of Urology at Fox Chase Cancer Center in the US. He noted that lifestyle interventions—including maintaining a healthy weight, controlling blood sugar and blood pressure, and quitting smoking—can substantially reduce risk. The study also revealed wide geographical and gender-based disparities in incidence and survival. Five-year survival rates currently range between 40% and 75%, with wealthier nations expected to benefit from early detection through routine imaging and better access to advanced treatments such as surgery and radiotherapy. The findings add to a broader global concern: a recent Lancet analysis estimated that annual cancer deaths of all types may climb by 75% over the next 25 years. Alarmingly, 40% of these deaths are linked to 44 preventable risk factors, including poor diet, tobacco, and high blood sugar. Source: PTI

Kidney Cancer Cases Could Nearly Double Worldwide by 2050: Study Read More »

Indian Scientists Develop Breakthrough Nanomaterial to Stimulate Brain Cells Without Surgery

ardorcomm news

In a pioneering development, researchers at the Institute of Nano Science and Technology (INST), under the Department of Science and Technology (DST), have created a nanomaterial that can stimulate brain cells without the use of electrodes, lasers, or magnetic devices. The material, known as graphitic carbon nitride (g-C₃N₄), has shown the ability to enhance neuron growth, communication, and dopamine production. Significantly, it also helped reduce harmful proteins associated with Parkinson’s disease in animal models, offering a potential breakthrough in non-invasive therapies for neurological disorders. Unlike current treatments such as deep brain stimulation (DBS), which require surgical implants, g-C₃N₄ interacts naturally with neurons. Acting like a smart semiconductor switch, it generates subtle electric fields in response to neuronal activity, opening calcium channels that encourage healthy cell growth and connectivity. The INST team confirmed their hypothesis through extensive tests, including Ca²⁺ imaging studies, gene expression analysis, and immunofluorescence assays, proving the material’s unique ability to modulate neurons without fatigue. Lead researcher Dr. Manish Singh described it as the first evidence of semiconducting nanomaterials directly influencing neuronal behavior without external triggers. He noted that the findings could transform treatments for Alzheimer’s, Parkinson’s, and brain injuries, while also laying the foundation for futuristic applications like brain-inspired computing using lab-grown brain organoids. Although more preclinical and clinical studies are required, the discovery signals a paradigm shift in neuromodulation and tissue engineering, with immense therapeutic potential for an ageing global population increasingly affected by neurodegenerative diseases. Source: PIB

Indian Scientists Develop Breakthrough Nanomaterial to Stimulate Brain Cells Without Surgery Read More »

Govt Aims to Meet WHO’s 1:1000 Doctor-Patient Ratio, Says NMC Chairman Abhijat Sheth

ardorcomm news

The government is determined to increase the number of doctors across India in a uniform manner to meet the World Health Organization’s (WHO) standard of a 1:1000 doctor-patient ratio, National Medical Commission (NMC) Chairman Abhijat Sheth said on Saturday. Speaking at the 11th convocation of the Atal Bihari Vajpayee Institute of Medical Sciences (ABVIMS) and Dr. Ram Manohar Lohia Hospital in New Delhi, Sheth congratulated the graduating doctors, their families, and faculty members for their commitment to the medical profession. He underlined the government’s efforts to not only bridge the doctor-patient gap but also to achieve a balanced undergraduate-to-postgraduate (UG-PG) ratio of 1:1, which would bring India’s healthcare standards closer to those of developed nations. Sheth also highlighted initiatives by the NMC and the National Board of Examinations in Medical Sciences, including the integration of skill-based training, virtual learning, and competency-driven education alongside traditional methods. He urged students to focus on their health, resilience, and continuous learning throughout their careers. Addressing the graduating batch, Director General of Health Services (DGHS) Dr. Sunita Sharma reminded them that receiving a medical degree comes with a profound responsibility — to heal, lead, and serve. She emphasized that whether in clinical practice, research, or teaching, doctors must let their work be guided by empathy, evidence, and excellence. Calling medicine a noble calling rooted in compassion, she encouraged young doctors to stay humble and grounded as they advance in their professional journeys. Source: PTI

Govt Aims to Meet WHO’s 1:1000 Doctor-Patient Ratio, Says NMC Chairman Abhijat Sheth Read More »

IMA Andhra Pradesh joins hands with US research centre to tackle urinary tract diseases

ardorcomm news

The Andhra Pradesh chapter of the Indian Medical Association (IMA-AP) has partnered with Ipseity, a US-based research centre, to conduct an in-depth study on urinary tract diseases. Highlighting the growing concern, IMA-AP president Dr. G. Nanda Kishore said that chronic urinary tract conditions, especially recurring infections, pose a serious public health challenge. He noted that many antibiotics currently used in treatment are failing to fully eradicate infections, leaving patients vulnerable to repeated urinary tract infections (UTIs). As part of the initiative, urine samples from 300 chronic UTI patients across Andhra Pradesh will be collected for advanced testing. These will include molecular PCR and antimicrobial resistance (AMR) profiling, aimed at identifying the most effective antibiotics for complete recovery. According to Dr. Kishore, the study could play a crucial role in reducing both health risks and financial strain on patients. He also urged doctors across the state to actively support the programme. Dr. Sandeep Nadendla, CEO of Ipseity and a native of Andhra Pradesh, said his mission is to bring advanced diagnostic solutions and medical research closer to the local population. He stressed that collaboration between practicing doctors and research institutions is key to ensuring early detection and better treatment outcomes for diseases affecting communities. Source: TNN

IMA Andhra Pradesh joins hands with US research centre to tackle urinary tract diseases Read More »

Chronic Disease Deaths Rising in India, Women Face Higher Risk: Lancet Report

ardorcomm news

India has recorded a troubling rise in deaths from chronic illnesses such as heart disease, diabetes, and cancer, with women disproportionately affected, according to a new global analysis published in The Lancet. The study, led by researchers at Imperial College London in collaboration with the World Health Organization (WHO), assessed the probability of dying from non-communicable diseases (NCDs) before the age of 80 across 185 countries. Findings show that while 4 out of 5 countries witnessed a decline in premature mortality linked to chronic conditions between 2010 and 2019, India — along with Papua New Guinea — bucked the trend, reporting increases for both men and women. Alarmingly, Indian women experienced a steeper rise in risk compared to men. “Heart disease and diabetes were major contributors to India’s increase in deaths from chronic illnesses,” the researchers noted. By contrast, nations such as China, Egypt, Nigeria, Russia, and Brazil reported reductions in NCD-related mortality for both sexes. Globally, declines in deaths from cancers and cardiovascular conditions were offset by increases in fatalities caused by dementia, alcohol use disorders, and pancreatic and liver cancers. The findings are significant in the context of the UN’s Sustainable Development Goal to reduce premature mortality from NCDs by one-third by 2030. Researchers warn that without urgent investment and targeted interventions, India risks falling further behind in tackling its chronic disease burden. The report comes just ahead of the UN General Assembly’s high-level meeting on September 25, where world leaders will revisit global strategies to prevent and control NCDs, as well as promote mental health and well-being. Source: PTI Photo Credit: iStock  

Chronic Disease Deaths Rising in India, Women Face Higher Risk: Lancet Report Read More »

Russia Declares Cancer Vaccine ‘Enteromix’ Ready for Clinical Use; To Be Provided Free for Patients

ardorcomm news

Russia has announced that its personalised cancer vaccine, Enteromix, developed using advanced mRNA technology, is now ready for clinical application following successful early trials. The vaccine, created by the National Medical Research Radiology Centre in collaboration with the Engelhardt Institute of Molecular Biology, was unveiled at the 10th Eastern Economic Forum in Vladivostok in September 2025, attracting global interest from 8,400 delegates representing 75 countries. Personalised Immunotherapy Unlike chemotherapy and radiation, which damage healthy cells alongside cancerous ones, Enteromix works by training the body’s immune system to recognise and destroy tumors. Each dose is tailored to a patient’s RNA profile, ensuring a highly individualised treatment with fewer side effects. The vaccine uses four harmless viral vectors to trigger immune responses that shrink tumors, slow their spread, and extend life expectancy. Clinical Trial Results In early-stage clinical trials involving 48 patients, Enteromix demonstrated strong results: Tumor sizes reduced by 60–80%. Tumor growth halted and in some cases reversed. Improved overall survival rates. No severe side effects reported. Effectiveness maintained across multiple doses. The initial version of Enteromix targets colorectal cancer, a leading cause of cancer-related deaths worldwide. Further versions for glioblastoma (brain cancer) and melanoma are also under development. Accessibility and Global Impact Russia’s Federal Medical and Biological Agency (FMBA), led by Veronika Skvortsova, confirmed that once regulatory approvals are secured, the vaccine will be distributed free of cost to patients, making advanced cancer therapy more accessible across all social groups. Enteromix is part of a growing global race to develop cancer vaccines using mRNA technology. Companies like BioNTech and Moderna are advancing similar personalised vaccines for pancreatic, lung, and skin cancers, while the UK’s Cancer Vaccine Launch Pad and India’s work on breast, oral, and cervical cancer vaccines show worldwide momentum in this field. Russia, however, is among the first to declare clinical readiness. Next Steps Despite promising results, Enteromix must undergo Phase 2 and Phase 3 clinical trials involving larger patient groups to confirm its safety and effectiveness before widespread use. Approval from Russia’s Ministry of Health and international health agencies will be critical for its rollout. If successful, Enteromix could become one of the first personalised mRNA cancer vaccines available to the public, offering a major breakthrough in global oncology treatment. Source: TOI Photo Credit: @SputnikInt/X   

Russia Declares Cancer Vaccine ‘Enteromix’ Ready for Clinical Use; To Be Provided Free for Patients Read More »